BCAB
Bioatla·NASDAQ
--
--(--)
--
--(--)
3.71 / 10
Netural
Money flow is encouraging at 7.41/10, reflecting positive fund inflows across block, small, medium, and large orders, though the overall trend is labeled negative. Analyst coverage is sparse—only one analyst with a Neutral rating—leading to a Netural consensus and low historical win rate (0.0%). This lack of strong institutional conviction tempers the positive flow narrative. Investors should weigh robust fund inflows against minimal analyst support.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-13
InstitutionJMP Securities
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of BCAB?
- BCAB holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.71/10 (Netural).
